Hostname: page-component-74656f9884-2dmjx Total loading time: 0 Render date: 2026-11-08T04:11:03.825Z Has data issue: false hasContentIssue false
  • English
  • Français

DTU I isolates of Trypanosoma cruzi induce upregulation of Galectin-3 in murine myocarditis and fibrosis

Published online by Cambridge University Press:  13 February 2014

MARÍA F. FERRER ,
CARLA A. PASCUALE ,
RICARDO M. GOMEZ  and
MARÍA S. LEGUIZAMÓN
MARÍA F. FERRER
Affiliation:
Instituto de Biotecnología y Biología Molecular, Universidad Nacional de La Plata, Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Argentina
CARLA A. PASCUALE
Affiliation:
Instituto de Microbiología y Parasitología Médica, Universidad de Buenos Aires-CONICET, Argentina Instituto de Investigaciones Biotecnológicas, Instituto Tecnológico de Chascomús, Universidad Nacional de San Martin-CONICET, Argentina
RICARDO M. GOMEZ*
Affiliation:
Instituto de Biotecnología y Biología Molecular, Universidad Nacional de La Plata, Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Argentina
MARÍA S. LEGUIZAMÓN*
Affiliation:
Instituto de Microbiología y Parasitología Médica, Universidad de Buenos Aires-CONICET, Argentina Instituto de Investigaciones Biotecnológicas, Instituto Tecnológico de Chascomús, Universidad Nacional de San Martin-CONICET, Argentina
*
* Corresponding authors. Ricardo M. Gómez, Instituto de Biotecnología y Biología Molecular, Facultad de Ciencias Exactas, Universidad Nacional de La Plata, Calle 49 y 115, 1900 La Plata, Argentina. E-mail: rmg@biol.unlp.edu.ar
* María Susana Leguizamón, Instituto de Microbiología y Parasitología Médica, Facultad de Medicina, Universidad de Buenos Aires, Paraguay 2155, Piso 13, 1121, Buenos Aires, Argentina. E-mail: sleguiza@fmed.uba.ar
Rights & Permissions [Opens in a new window]

Summary

Chagas heart disease is a major public concern since 30% of infected patients develop cardiac alterations. The relationship between Trypanosoma cruzi discrete typing units (DTUs) and the biological properties exhibited by the parasite population has yet to be elucidated. In this study, we analysed the expression of α-smooth muscle actin (α-SMA) and galectin-3 (Gal-3) associated with cardiac extracellular matrix (ECM) remodelling a murine chronic cardiomyopathy induced by Tc I genotypes. We found the induction of myocarditis was associated with the upregulation of Col I, α-SMA, Gal-3, IFN-γ and IL-13, as analysed by q-PCR. In myocardial areas of fibrosis, the intensity of myocarditis and significant ECM remodelling correlated with the presence of Col I-, Gal-3- and α-SMA-positive cells. These results are promising for the further efforts to evaluate the relevance of Gal-3 in Chagas heart disease, since this galectin was proposed as a prognosis marker in heart failure patients.

Keywords

Chagas diseasegalectin-3fibrosissmooth muscle actinDTU

Information

Type
Research Article
Information
Parasitology , Volume 141 , Issue 6 , May 2014 , pp. 849 - 858
Check for updates
Copyright
Copyright © Cambridge University Press 2014 

INTRODUCTION

Chagas disease, which is caused by Trypanosoma cruzi, is a major neglected tropical disease, with more than 8 million infected people in the endemic region (WHO, 2002; Rassi et al. Reference Rassi, Rassi and Marin-Neto2010). The infection can also spread, including in non-endemic countries, mainly by blood transfusion and congenital transmission (WHO, 2002). While the acute phase of the infection is usually asymptomatic, 30% of infected patients develop cardiac alterations and 10% develop megaoesophagus, megacolon, or mixed alterations late during the chronic phase of the infection. In South America, megaviscera and severe cardiomegaly were both observed, but with different rates of incidence between the countries. In Mexico and Central America, the prevalence of megaviscera is rare (Rassi et al. Reference Rassi, Rassi and Marin-Neto2010). The reasons for the different geographical distributions of these clinical manifestations remain unknown (Campbell et al. Reference Campbell, Westenberger and Sturm2004; Marin-Neto et al. Reference Marin-Neto, Cunha-Neto, Maciel and Simoes2007; Rassi et al. Reference Rassi, Rassi and Marin-Neto2010). Chagas heart disease (ChHD) is a major public health concern, and it is estimated that 20 000 patients die annually in endemic countries (PAHO, 2007). Trypanosoma cruzi populations cluster into six discrete typing units (DTU), named Tc I–VI (Zingales et al. Reference Zingales, Andrade, Briones, Campbell, Chiari, Fernandes, Guhl, Lages-Silva, Macedo, Machado, Miles, Romanha, Sturm, Tibayrenc, Schijman and Second Satellite2009). The relationship between DTUs and the diverse biological properties, including virulence, invasion and tissue tropism, exhibited by T. cruzi strains is still not understood. It was proposed that Tc II, V and VI are most frequently implicated in the pathogenesis of chronic Chagas disease in southern South America, where severe megasyndromes are commonly observed. In contrast, while Tc I was initially considered to be less pathogenic (innocuousness) primarily in Mexico, Central America and northern South America (Di Noia et al. Reference Di Noia, Buscaglia, De Marchi, Almeida and Frasch2002; Feliciangeli et al. Reference Feliciangeli, Dujardin, Bastrenta, Mazzarri, Villegas, Flores and Munoz2002; Miles et al. Reference Miles, Feliciangeli and de Arias2003; Campbell et al. Reference Campbell, Westenberger and Sturm2004; Macedo et al. Reference Macedo, Machado, Oliveira and Pena2004; Freitas et al. Reference Freitas, Lages-Silva, Crema, Pena and Macedo2005; Carranza et al. Reference Carranza, Valadares, D'Avila, Baptista, Moreno, Galvao, Chiari, Sturm, Gontijo, Macedo and Zingales2009), in recent years it has been detected in cardiac tissue of patients in the end-stage of ChHD from Brazil and Argentina (Teixeira et al. Reference Teixeira, da Silva, Marcili, Umezawa, Shikanai-Yasuda, Cunha-Neto, Kalil, Stolf and Stolf2006; Burgos et al. Reference Burgos, Diez, Vigliano, Bisio, Risso, Duffy, Cura, Brusses, Favaloro, Leguizamon, Lucero, Laguens, Levin, Favaloro and Schijman2010).

The myocardium invasion by T. cruzi destroys cardiac myocytes and induces damage caused by inflammation, which results in the loss of cardiomyocytes, hypertrophy of the surviving myocytes, conduction network damage, chamber dilation, proliferation of cardiac fibroblasts (CFs), and significant extracellular matrix (ECM) remodelling that may result in severe cardiac insufficiency and in the eventual need for a cardiac transplant (WHO, 2002; Marin-Neto et al. Reference Marin-Neto, Cunha-Neto, Maciel and Simoes2007; Tanowitz et al. Reference Tanowitz, Machado, Jelicks, Shirani, de Carvalho, Spray, Factor, Kirchhoff and Weiss2009; Rassi et al. Reference Rassi, Rassi and Marin-Neto2010). Although the pathogenesis of T. cruzi infection is not completely understood, its persistence has been postulated to be a co-requisite, or possibly a prerequisite, for the development of ChHD (Tarleton, Reference Tarleton2003). It has been demonstrated that during the cardiac ECM remodelling processes, the phenotypic transformation of CFs to myofibroblasts is a key event. Myofibroblasts are highly active cells that express α-smooth muscle actin (α-SMA) and exhibit increased proliferative, migratory and secretory properties. Under normal circumstances, the myofibroblasts are removed from the repaired wound site by apoptosis (Desmouliere et al. Reference Desmouliere, Redard, Darby and Gabbiani1995; Gurtner et al. Reference Gurtner, Werner, Barrandon and Longaker2008; Shi et al. Reference Shi, Liu, Bai, Cui, Li, Li, Hu and Wei2011). However, persistence of myofibroblasts can facilitate hypertrophic scarring and fibrosis, which results in myocardial stiffness and impairment of cardiac function (Sun and Weber, Reference Sun and Weber2000; Frangogiannis, Reference Frangogiannis2006).

Galectin-3 (Gal-3), which is the only galectin with a chimera-type in the family of β-galactoside-binding animal lectins, has several physiological and pathological associated roles (Liu and Rabinovich, Reference Liu and Rabinovich2010). During experimental T. cruzi infection, Gal-3 was upregulated in B cells (Acosta-Rodriguez et al. Reference Acosta-Rodriguez, Montes, Motran, Zuniga, Liu, Rabinovich and Gruppi2004) and dendritic cells (Vray et al. Reference Vray, Camby, Vercruysse, Mijatovic, Bovin, Ricciardi-Castagnoli, Kaltner, Salmon, Gabius and Kiss2004). Gal-3 binds to a trypomastigote surface mucin (Moody et al. Reference Moody, Ochieng and Villalta2000; Turner et al. Reference Turner, Lima and Villalta2002) and on human coronary artery smooth muscle cells in a lectin-like manner (Kleshchenko et al. Reference Kleshchenko, Moody, Furtak, Ochieng, Lima and Villalta2004). It has been suggested that it plays a role in a trypanosome trapping mechanism, which enables the parasite to accumulate in the basement membrane prior to invasion (Villalta et al. Reference Villalta, Scharfstein, Ashton, Tyler, Guan, Mukherjee, Lima, Alvarez, Weiss, Huang, Machado and Tanowitz2009). Gal-3 has recently been reported to be involved in heart failure (HF) development in different experimental models. In these systems, its upregulation was associated with macrophages migration, fibroblast activation and the induction of cardiac ECM remodelling in the progression to HF (de Boer et al. Reference de Boer, Yu and van Veldhuisen2010). In addition, Gal-3 was also upregulated in human hypertrophied hearts and plasma from patients with acute or chronic HF (Lok et al. Reference Lok, Van Der Meer, de la Porte, Lipsic, Van Wijngaarden, Hillege and van Veldhuisen2010). The role of Gal-3 in the cardiac alterations induced by T. cruzi has not been fully investigated (Soares et al. Reference Soares, de Lima, Rocha, Vasconcelos, Rogatto, dos Santos, Iacobas, Goldenberg, Iacobas, Tanowitz, de Carvalho and Spray2010).

In order to better understand the mechanisms involved in ChHD pathogenesis, we analysed the expression of Gal-3 associated with cardiac collagen remodelling in a murine chronic cardiomyopathy induced by Tc I strains of T. cruzi.

MATERIALS AND METHODS

Parasites

The Ac and Hc strains of T. cruzi, which are members of DTU Tc I, were isolated from patients (Risso et al. Reference Risso, Garbarino, Mocetti, Campetella, Gonzalez Cappa, Buscaglia and Leguizamon2004). The remaining isolates (3 Tc V and 1 Tc VI) were also obtained from patients and the DTU were identified as described (Burgos et al. Reference Burgos, Risso, Breniere, Barnabe, Campetella and Leguizamon2013).

Mice

Weanling (21 days old) male CF1 mice were provided by the Institute of Medical Microbiology and Parasitology (IMPAM), UBA-CONICET.

Ethics statement

The protocol of this study was approved by the Committee on the Ethics of Animal Experiments of the Universidad Nacional de San Martín (UNSAM), which also approved the protocol development under the recommendations of the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. The Three R's rule was followed. Therefore the animal number used was reduced to the minimal amount required to obtain statistically valid data.

Experimental design

Groups of five mice were inoculated intraperitoneally with 5×104 bloodstream trypomastigotes. Mice were observed daily to determine mortality and morbidity. Cardiac muscle samples were obtained from mice that were euthanased at 3 or 5 (DTU V and VI, respectively) months post-infection (mpi). Animals inoculated with equal volumes of PBS-BSA (mock-infected) were used as negative controls. Circulating parasites were monitored starting at 11 days post-infection (dpi) and parasitaemia was evaluated using a hemacytometer (Risso et al. Reference Risso, Garbarino, Mocetti, Campetella, Gonzalez Cappa, Buscaglia and Leguizamon2004).

Histopathology

Heart samples were removed and split along the longitudinal axis. One-half was fixed in 4% paraformaldehyde, embedded in paraffin, sections stained with hematoxylin-eosin (HE), and examined for the presence of myocarditis according to the parameters based on cell infiltration and necrosis of muscle cells as previously reported (Feldman and McNamara, Reference Feldman and McNamara2000).

To obtain a myocarditis score for each sample, 5 μm thick sections were used for HE staining. All fields of each section were analysed. The severity of inflammation was graded as follows: grade 0 = no lesions; grade 1 = involvement of a single muscle fibre or <5 muscle fibres; grade 2 = a lesion involving 5–10 muscle fibres; grade 3 = 10–20 muscle fibres; and grade 4 = diffuse, extensive lesions. When multiple lesions with the same grade were found in a single muscle block or marked fibrosis was observed, 0·5 points were added to the grade. All slides were evaluated independently by researchers who were blinded to the sample status. The picrosirius red (PSR) technique for collagen fibres (Junqueira et al. Reference Junqueira, Bignolas and Brentani1979) was carried out as previously described (Gomez et al. Reference Gomez, Castagnino and Berria1992). Briefly, sections were hydrated, washed, immersed in 0·02% aqueous phosphomolybdic acid, stained with 0·1% Sirius red F3BA in saturated aqueous picric acid, washed in 0·01 N HCl, stained with hematoxylin, and then dehydrated, mounted and observed using a Nikon E200 microscope.

Immunohistochemistry

Immunohistochemistry was performed as previously described (Gomez et al. Reference Gomez, Vieira, Schattner, Malaver, Watanabe, Barbosa, Abreu, de Morais, Cifuente, Atzingen, Oliveira, Vasconcellos and Nascimento2008) with minor modifications. Briefly, after rehydration, the tissue Pro-Bond Plus sections were heated three times for 5 min in a 10 mm citrate buffer in a microwave oven. The sections were then cooled and immersed in 3% H2O2 for 15 min, and incubated in 5% normal goat serum in PBS for 20 min at room temperature. The samples were incubated with a primary rat monoclonal anti-Gal-3 antiserum (Clone M3/38; 1 : 50 dilution) or mouse monoclonal anti-α-smooth muscle actin (α-SMA, DAKO; 1 : 50 dilution) for 1 h at room temperature. The secondary antibody was conjugated to peroxide-labelled dextran polymer (DAKO EnVision). Diaminobenzidine (DAB)/hydrogen peroxidase substrate was added for 10–20 min to reach the appropriate intensity and then the slides were rinsed with distilled water. Immunostained sections were counterstained with hematoxylin for 1 min, washed under tap water, rinsed with distilled water, and dehydrated in increasing ethanol concentrations followed by xylene (each treatment, 5 min). They were observed under a Nikon E200 photomicroscope.

DNA and RNA isolation and RT-PCR

Total DNA or RNA was isolated from half heart samples by mechanical homogenization and Trizol (Invitrogen), as recommended by the manufacturer. The DNA or RNA was resuspended in 100 μL nuclease-free water (Epicenter) and quantified using a spectrophotometer (Nanodrop spectrophotometer ND-1000). Prior to cDNA synthesis, DNase treatment was performed with an RNase free DNase Kit (Qiagen). cDNA was synthesized from 500 ng of total RNA with 15 mm random hexamers and MMLV reverse transcriptase (Promega), according to the manufacturer's instructions.

Real-time PCR

For q-PCR studies, PCR amplification and analysis were performed with a Line-Gene K instrument and software (Bioer). The 5× HOT FIREPol® EvaGreen® qPCR Mix Plus was used for all reactions following the manufacturer's instructions. For PCR efficiency calculations, 10-fold serial dilutions of Standard cDNA samples were used. Cycle threshold (Ct) values were obtained for each individual reaction, and the Ct of the ubiquitously host-expressed β-actin was subtracted to obtain the values for CCL-2, CXCL-10, pro-collagen type I, α-SMA, Gal-3, TGF-β1, IL-10, IL-13 and IFN-γ normalized, respectively (Jaquenod De Giusti et al. Reference Jaquenod De Giusti, Alberdi, Frik, Ferrer, Scharrig, Schattner and Gomez2011). Parasite burden was assessed as described previously (Solana et al. Reference Solana, Ferrer, Novoa, Song and Gomez2012). Briefly, a sequence of the satellite nuclear repeat (SNR) was amplified and the number of parasites was referred to that of the host cells. Host cell number was assessed by quantifying the single copy murine-specific TNF-α gene. The primer sequences and sizes of the amplified fragments are shown in Table 1.

Table 1.

Primers used in q-PCR assays

a SNR, satellite nuclear repeat.

Statistics

Data were expressed as the mean±s.e.m. and were analysed by one-way analysis of variance (ANOVA) followed by Bonferroni multiple comparison test to determine significant differences between groups. P<0·05 was considered statistically significant.

RESULTS

Human isolates belonging to DTU I were associated with heart disease of different severity

To study the progression of the murine infection and its eventual effect on the heart, we used human isolates of T. cruzi belonging to DTU I, V and VI. Their evolution was studied by monitoring circulating parasites, mortality and heart damage during the chronic phase at 3–5 mpi. Results showed that only the two isolated Tc I samples, named Ac and Hc, induced mortality (6%) and quantifiable parasitaemia by hemocytometer. The remaining isolates induced low circulating parasite levels. Ac and Hc trypomastigotes were detected from 11 dpi, but quantified from 14 dpi (Fig. 1A). Both strains induced maximal parasitaemia values between 20–50 dpi and trypomastigotes were undetectable by this method after 70 dpi. Additionally, q-PCR of the SNR gene was used to study the parasitic burden in heart tissue samples of mice inoculated with Ac and Hc strains at 90 dpi, as well as the mock-infected mice. As expected, no amplification was observed in samples from mock-infected mice. In contrast, both Ac- and Hc-inoculated mice exhibited cardiac parasite burden, with higher values in the former (P<0·05; Fig. 1B). For histopathological analysis, myocardial samples from mock-infected mice served as controls for routine HE staining and, as expected, showed no abnormalities (Fig. 1C). The findings we observed in infected animals consisted, to varying degrees of focal myocarditis, featuring a few necrotic myocytes with pyknotic nuclei and basophilic cytoplasm, together with slight mononuclear cell infiltrates within or surrounded by necrotic fibres. The degree of myocarditis ranged from minimum to mild for DTU V and VI (scoring 0·5–1), to moderate to intense for both DTU I Hc and Ac strains (scoring 2 and 2·6, respectively; Fig. 1D–I). CCL-2 and CXCL-10 mRNA expression was evaluated as established molecular markers of myocarditis (Hardison et al. Reference Hardison, Wrightsman, Carpenter, Lane and Manning2006; Paiva et al. Reference Paiva, Figueiredo, Kroll-Palhares, Silva, Silverio, Gibaldi, Pyrrho Ados, Benjamim, Lannes-Vieira and Bozza2009). Both Hc- and Ac-infected mice showed increased significant CCL-2 and CXCL-10 mRNA levels compared with mock-infected mice (P<0·05, Fig. 1J and K).

Fig. 1.

DTU I isolates induce murine myocarditis to different intensities. (A) Parasitaemia levels were monitored, in T. cruzi Hc- and Ac-inoculated CF1 mice, from 14 days post-infection and the number of parasites/mL was calculated. (B) Parasite burden at hearts was quantified by q-PCR of the SNR gene and expressed as number of parasites per number of host cells. Hc- and Ac-infected CF1 mice were euthanased at 3 mpi. Bars represent the s.e.m. for assays performed on a group of five mice. Each organ was analysed independently. mpi, months post-infection. *P<0·05. (C–I) Representative histopathology sections. Samples were harvested and processed for routine staining with HE. (C) Mock-infected heart tissue. (D) T. cruzi DTU I (Hc)-infected CF1 mice showed slight myocarditis with minimal mononuclear cell infiltrate (arrows). (E) T. cruzi DTU I (Ac)-infected CF1 mice showed a moderate to intermediate myocarditis with predominant mononuclear cell infiltrates localized between necrotic muscle fibres (arrows). (F–H) T. cruzi DTU V and (I) T. cruzi DTU VI infected-CF1 mice showed normal or minimal myocarditis. Scale bar: 80 μm. (J) Quantitative measurement of CCL-2 mRNA in heart samples from mock-infected or infected animals at 3 mpi. (K) Quantitative measurement of CXCL-10 mRNA in heart samples from mock-infected or infected animals at 3 mpi. Bars represent the s.e.m. of assays from a group of 5 mice. Each organ was analysed in triplicate by q-PCR and normalized to host β-actin expression; *P<0·05 vs mock-infected.

Higher cardiac parasitic burden and pathology were associated with increased fibrosis

To study if cardiac parasitic burden and pathology correlated with fibrosis, we first analysed the levels of pro-Collagen I mRNA in samples from Hc- and Ac-infected mice. The results showed that expression was higher in samples from the Ac-inoculated animals (P<0·05; Fig. 2A). To confirm this, we also employed the PSR staining of cardiac samples from Ac- and Hc-infected animals, as well as of mock-infected controls. The PSR staining showed normal collagen distribution in samples from mock-infected mice (Fig. 2B). In contrast, we observed an enhancement of the collagen matrix in samples from Hc- and Ac-infected animals, represented by increased numbers of collagen fibres in the intercellular spaces and along the major axis of affected myocytes. The ECM remodelling was less intense in samples from Hc-inoculated mice as compared with Ac-inoculated mice, where, in several areas, the collagen pattern had undergone striking alterations resulting in a highly distorted lattice (Fig. 2C and D).

Fig. 2.

DTU I isolates induce murine cardiac fibrosis of different intensity. (A) Quantitative measurement of pro-collagen I mRNA in heart samples from mock-infected or infected animals at 3 mpi. Bars represent the s.e.m. of assays from a group of 5 mice. Each organ was analysed in triplicate by q-PCR and normalized to host β-actin expression; *P<0·05; (B–D) PSR staining of representative heart histology sections from T. cruzi Hc- and Ac-inoculated CF1 male mice at 3 mpi. As revealed by PSR staining, a collagen matrix made up by fibres was located within the intercellular spaces in; (B) mock-infected; (C) Hc-infected, and; (D) Ac-infected CF1 mice. Scale bar: 80 μm. mpi, months post-infection. Main PSR stains are indicated by arrows.

Tc I-induced cardiac ECM remodelling correlates with high levels of Gal-3 and activated myofibroblasts

The relevance of Gal-3 and myofibroblasts in the ECM remodelling has been described, and their enhanced expression and hyperplasia has been associated with liver (Henderson et al. Reference Henderson, Mackinnon, Farnworth, Poirier, Russo, Iredale, Haslett, Simpson and Sethi2006) and renal fibrosis (Henderson et al. Reference Henderson, Mackinnon, Farnworth, Kipari, Haslett, Iredale, Liu, Hughes and Sethi2008).

Here, we studied the expression of Gal-3 and α-SMA antigen in hearts from mock-, Hc- or Ac-infected animals. As expected, the results showed a significant increase in the levels of α-SMA (P<0·05; Fig. 3A) and Gal-3 transcripts in samples from Ac-infected mice as compared with the mock-infected controls (P<0·01; Fig. 3E). By immunohistochemistry staining, α-SMA antigen was only detectable in cells located in the tunica media of vessels in the samples from mock-infected mice. Meanwhile, in samples from infected mice, an additional slight staining was observed in mononuclear cells located in the interstitium (Fig. 3B–D), with staining being higher in fibrotic areas. The Gal-3 antigen was primarily detected in cells located in the interstitium, with it also being higher in fibrotic areas (Fig. 3F–H). Interestingly, both transcripts, as well as protein expression levels, were minimal in mock-infected mice, intermediate in Hc-inoculated mice and maximal in Ac-inoculated (Fig. 3A–H).

Fig. 3.

Gal-3 and α-SMA expression in T. cruzi Hc- and Ac-inoculated CF1 male mice at 3 mpi. Quantitative measurements of (A) α-SMA and (E) Gal-3 mRNA expression in heart samples from CF1 mock-infected (CF1 mock) and Hc- and Ac-infected (CF1+Hc and CF1+Ac, respectively) animals at 3 mpi. Bars represent the s.e.m. of assays from a group of 5 mice. Each organ was analysed in triplicate by q-PCR and normalized to host β-actin expression; *P<0·05, **P<0·01. Immunohistochemistry of heart sections, from (B and F) mock-,-; (C and G) Hc-, and (D and H) Ac-infected CF1 mice, with antiserum specific for α-smooth muscle actin (α-SMA) or galectin-3 (Gal-3) at 3 mpi. Scale bar: 80 μm. mpi, months post-infection. Positive foci are indicated by arrows.

mRNA cytokine levels in hearts with interstitial fibrosis triggered by Tc I infection

Using q-PCR, we measured the mRNA levels of several cytokines that had been previously reported to have a role in the development of ChHD in the hearts of Ac-infected mice (Araujo-Jorge et al. Reference Araujo-Jorge, Waghabi, Bailly and Feige2012; Calvet et al. Reference Calvet, Melo, Garzoni, Oliveira, Neto, Meirelles and Pereira2012; Machado et al. Reference Machado, Dutra, Esper, Gollob, Teixeira, Factor, Weiss, Nagajyothi, Tanowitz and Garg2012; Roffe et al. Reference Roffe, Rothfuchs, Santiago, Marino, Ribeiro-Gomes, Eckhaus, Antonelli and Murphy2012). The IL-13 and IFN-γ mRNA expression levels were significantly elevated in Ac-infected CF1 mice at 3 mpi compared with their expression in mock-infected CF1 mice (P<0·01 and <0·05, respectively). In contrast, there were no significant differences in the expression levels of TGF-β1 and IL-10 at 3 mpi when compared to mock-infected mice (Fig. 4A–D).

Fig. 4.

mRNA cytokine levels in Ac-infected CF1 mice at 3 mpi. Quantitative measurement of (A) TGF-β1, (B) IL-13, (C) IFN-γ and (D) IL-10 mRNA expression in cardiac samples from mock-infected (CF1 mock) or infected (CF1+Ac) mice. Organs were collected at 3 mpi. Bars represent the s.e.m. of assays performed on samples from a group of 5 mice. Each organ was analysed in triplicate by q-PCR and normalized to host β-actin expression; *P<0·05 and **P<0·01 vs controls. mpi, months post-infection.

DISCUSSION

In the present study, we analysed different T. cruzi isolates obtained from Argentine patients and genotyped as DTU I, V or VI. Only those belonging to Tc I progressed towards a chronic infection in mice and had a significant impact on cardiac tissue.

Previously, the Tc I genotype was proposed to be more benign and was not associated with ChHD in South American patients (Feliciangeli et al. Reference Feliciangeli, Dujardin, Bastrenta, Mazzarri, Villegas, Flores and Munoz2002; Miles et al. Reference Miles, Feliciangeli and de Arias2003; Campbell et al. Reference Campbell, Westenberger and Sturm2004). However, in recent years, the persistence of Tc I strains in human cardiac tissue has been correlated with ChHD (Burgos et al. Reference Burgos, Diez, Vigliano, Bisio, Risso, Duffy, Cura, Brusses, Favaloro, Leguizamon, Lucero, Laguens, Levin, Favaloro and Schijman2010; Ramirez et al. Reference Ramirez, Guhl, Rendon, Rosas, Marin-Neto and Morillo2010). Although both Tc I genotypes, analysed here, induced the persistence of the parasites in cardiac tissue that is associated with chronic myocarditis and significant cardiac ECM remodelling in mice, they differed in the parasite burden and the intensity of the murine ChHD that was induced. These differences may be related to the significant genetic diversity observed in this DTU, which is what prompted the proposal for the subdivision of DTU I (Guhl and Ramirez, Reference Guhl and Ramirez2011).

Taken together, our results suggest that during the host-parasite interplay, in addition to the genetic background of the parasite, other properties are relevant to the outcome of heart disease.

We found that relatively small levels of T. cruzi DNA, detected by q-PCR, persisted in diseased heart muscle, as has been reported in previous studies (Brandariz et al. Reference Brandariz, Schijman, Vigliano, Arteman, Viotti, Beldjord and Levin1995). Moreover, the levels of T. cruzi burden in CF1 mice correlated with the degree of ECM remodelling induced. These findings are in agreement with the key role of parasite persistence in tissues during the acute phase, and the development of cardiopathy late during infection (Tarleton, Reference Tarleton2001, Reference Tarleton2003). In this regard, T. cruzi persistence may result in cytolysis, which leads to the release of host antigens and large quantities of inflammatory mediators, which can enhance bystander activation (Bonney and Engman, Reference Bonney and Engman2008).

In humans, dilation of the left ventricle and cardiac fibrosis are hallmarks of idiopathic dilated cardiomyopathy and ChHD. Enhanced fibrosis is characterized by a disproportionate accumulation of fibrillar collagen, leading to stiffening of the ventricles and impaired diastolic filling (Marin-Neto et al. Reference Marin-Neto, Cunha-Neto, Maciel and Simoes2007; Rassi et al. Reference Rassi, Rassi and Marin-Neto2010; Machado et al. Reference Machado, Dutra, Esper, Gollob, Teixeira, Factor, Weiss, Nagajyothi, Tanowitz and Garg2012). The PSR staining was sensitive enough to monitor how collagen fibres accumulated. It could be speculated that such modifications must inevitably affect cardiac function.

Although there have been no previous reports of α-SMA-positive cells in T. cruzi-induced ChHD, the presence of myofibroblasts in ChHD was described in an electron microscopy study (Andrade and Grimaud, Reference Andrade and Grimaud1986). As was expected for cells that are considered as the main source of collagen, our study shows that myofibroblasts were colocalized with accumulated collagen, further indicating a relevant role for these cells in the development of ChHD fibrosis. In addition, myofibroblasts-myocyte coupling has the potential to promote reentry-induced arrhythmias (Zlochiver et al. Reference Zlochiver, Munoz, Vikstrom, Taffet, Berenfeld and Jalife2008), which are frequently observed in ChHD patients. Importantly, myofibroblasts are also a significant source of proinflammatory cytokines, including TNF-α and IL-1β, which have a known deleterious effect on the myocardium (Kubota et al. Reference Kubota, McTiernan, Frye, Slawson, Lemster, Koretsky, Demetris and Feldman1997; Cain et al. Reference Cain, Meldrum, Dinarello, Meng, Joo, Banerjee and Harken1999; Haudek et al. Reference Haudek, Taffet, Schneider and Mann2007).

The enhanced expression of Gal-3 that we observed in Tc I-infected animals agrees with previous reports of its upregulated expression following T. cruzi infection (Soares et al. Reference Soares, de Lima, Rocha, Vasconcelos, Rogatto, dos Santos, Iacobas, Goldenberg, Iacobas, Tanowitz, de Carvalho and Spray2010). Our findings confirm and extend these results since they were obtained using different mice and T. cruzi strains. The parasitological treatment of patients in the indeterminate clinical phase is now recommended to avoid or attenuate cardiac alterations. Therefore, the availability of a biomarker to identify those patients that will progress to ChHD is urgently needed. As such, the results presented here are encouraging for further efforts to evaluate the relevance of Gal-3 in ChHD, since this galectin was proposed as a prognosis marker in HF patients not of chagasic aetiology.

The immunohistochemistry studies showed that the enhanced expression of Gal-3 was primarily located in the cytoplasm of interstitial cells, most likely macrophages (Sato and Hughes, Reference Sato and Hughes1994) and/or fibrocytes (Pilling et al. Reference Pilling, Fan, Huang, Kaul and Gomer2009). It has been shown that Gal-3 is required for differentiation of cultured hepatic stellate cells into myofibroblasts and that disruption of the galectin-3 gene blocks myofibroblast differentiation and pro-Collagen I expression, reducing hepatic fibrosis significantly (Henderson et al. Reference Henderson, Mackinnon, Farnworth, Poirier, Russo, Iredale, Haslett, Simpson and Sethi2006).

TGF-β1 has an assigned important role in T. cruzi-induced myocarditis, induction of myofibroblasts differentiation, and ECM remodelling (Araujo-Jorge et al. Reference Araujo-Jorge, Waghabi, Bailly and Feige2012). However, the TGF-β1 values obtained in our study suggest the possible involvement of other factors, such as the alteration in the ECM components, hyperoxia, and mechanical tension, as have been proposed for other models (Frangogiannis, Reference Frangogiannis2008). Moreover, in a recent in situ analysis of cytokines expression, the values for IFN-γ, but not TGF-β1, in hearts from ChHD, showed a correlation with HF and/or fibrosis intensity (Rocha Rodrigues et al. Reference Rocha Rodrigues, dos Reis, Romano, Pereira, Teixeira Vde, Tostes and Rodrigues2012). These results are in agreement with the TGF-β1 and IFN-γ expression levels in murine hearts following Ac infection. The upregulation of IFN-γ was also observed using microarrays and immunopathological studies on human cardiomyopathy samples (Bahia-Oliveira et al. Reference Bahia-Oliveira, Gomes, Rocha, Moreira, Lemos, Luz, Pereira, Coffman, Dias, Cancado, Gazzinelli and Correa-Oliveira1998; Cunha-Neto et al. Reference Cunha-Neto, Rizzo, Albuquerque, Abel, Guilherme, Bocchi, Bacal, Carrara, Ianni, Mady and Kalil1998, Reference Cunha-Neto, Dzau, Allen, Stamatiou, Benvenutti, Higuchi, Koyama, Silva, Kalil and Liew2005). It was proposed that the regulatory networks established during the chronic phase in humans are critical for the clinical progression (Dutra et al. Reference Dutra, Menezes, Villani, da Costa, da Silveira, Reis and Gollob2009). The shift towards a proinflammatory pathway was related to the development of cardiomyopathy (Dutra et al. Reference Dutra, Menezes, Villani, da Costa, da Silveira, Reis and Gollob2009). This is in agreement with high IFN-γ expression levels and the unmodified expression of IL-10 observed in our model.

A profibrotic role of IL-13 has been observed in different pathologies. The induction/activation of TGF-β1 through a MMP-9-dependent mechanism has been proposed (Zhu et al. Reference Zhu, Homer, Wang, Chen, Geba, Wang, Zhang and Elias1999; Lee et al. Reference Lee, Homer, Zhu, Lanone, Wang, Koteliansky, Shipley, Gotwals, Noble, Chen, Senior and Elias2001). However, the induction of fibrosis by IL-13 in a TGF-β1 independent manner was also described for hepatic fibrosis induced by Schistosoma mansoni infection (Kaviratne et al. Reference Kaviratne, Hesse, Leusink, Cheever, Davies, McKerrow, Wakefield, Letterio and Wynn2004). Our results show fibrosis development in a mixture of cytokines, with IL-13 upregulated and TGF-β1 maintained at normal levels. Although IL-13 has recently been reported to be elevated after acute T. cruzi-induced myocarditis (Roffe et al. Reference Roffe, Rothfuchs, Santiago, Marino, Ribeiro-Gomes, Eckhaus, Antonelli and Murphy2012), to the best of our knowledge, this is the first report of significant upregulation of its mRNA levels in ChHD.

In conclusion, our study shows that Tc I genotypes induce murine ChHD in association with Col I, α-SMA, Gal-3, IFN-γ and IL-13 upregulation. The significant ECM remodelling was associated with Col I-, Gal-3- and α-SMA-positive cells in the myocardial areas of the fibrosis. The Gal-3 upregulation encourages further efforts to evaluate the relevance of Gal-3 in ChHD, since this galectin was proposed as prognosis marker in HF patients. A biomarker is urgently needed to identify patients that evolve to cardiomyopathy and give them antiparasite treatment. Eventually, the present results may also justify studies using Gal-3 inhibitors to prevent or ameliorate cardiac fibrosis in chagasic patients.

ACKNOWLEDGEMENTS

RMG and MSL are members of the National Council of Science and Technology (CONICET). MFF is a fellow of the CONICET. CAP is a fellow of National Agency of Science and Technology (ANPCYT).

FINANCIAL SUPPORT

This work was supported by grants from the Universidad Nacional de La Plata and ANPCyT.

References

REFERENCES

Acosta-Rodriguez, E. V., Montes, C. L., Motran, C. C., Zuniga, E. I., Liu, F. T., Rabinovich, G. A. and Gruppi, A. (2004). Galectin-3 mediates IL-4-induced survival and differentiation of B cells: functional cross-talk and implications during Trypanosoma cruzi infection. Journal of Immunology 172, 493–502. doi: 10.1007/s00430-011-0192-3.CrossRefGoogle ScholarPubMed
Andrade, S. G. and Grimaud, J. A. (1986). Chronic murine myocarditis due to Trypanosoma cruzi – an ultrastructural study and immunochemical characterization of cardiac interstitial matrix. Memórias do Instituto Oswaldo Cruz 81, 29–41. doi: 10.1590/S0074-02761986000100004.CrossRefGoogle ScholarPubMed
Araujo-Jorge, T. C., Waghabi, M. C., Bailly, S. and Feige, J. J. (2012). The TGF-beta pathway as an emerging target for Chagas disease therapy. Clinical Pharmacology and Therapeutics 92, 613–621. doi: 10.1038/clpt2012102 [pii].CrossRefGoogle ScholarPubMed
Bahia-Oliveira, L. M., Gomes, J. A., Rocha, M. O., Moreira, M. C., Lemos, E. M., Luz, Z. M., Pereira, M. E., Coffman, R. L., Dias, J. C., Cancado, J. R., Gazzinelli, G. and Correa-Oliveira, R. (1998). IFN-gamma in human Chagas’ disease: protection or pathology? Brazilian Journal of Medical and Biological Research 31, 127–131. doi: 10.1590/S0100-879X1998000100017.Google Scholar
Bonney, K. M. and Engman, D. M. (2008). Chagas heart disease pathogenesis: one mechanism or many? Current Molecular Medicine 8, 510–518. doi: 10.2174/156652408785748004.CrossRefGoogle ScholarPubMed
Brandariz, S., Schijman, A., Vigliano, C., Arteman, P., Viotti, R., Beldjord, C. and Levin, M. J. (1995). Detection of parasite DNA in Chagas’ heart disease. Lancet 346, 1370–1371. doi: 10.1016/S0140-6736(95)92388-8.CrossRefGoogle ScholarPubMed
Burgos, J. M., Diez, M., Vigliano, C., Bisio, M., Risso, M., Duffy, T., Cura, C., Brusses, B., Favaloro, L., Leguizamon, M. S., Lucero, R. H., Laguens, R., Levin, M. J., Favaloro, R. and Schijman, A. G. (2010). Molecular identification of Trypanosoma cruzi discrete typing units in end-stage chronic Chagas heart disease and reactivation after heart transplantation. Clinical Infectious Disease 51, 485–495. doi: 10.1086/655680.CrossRefGoogle ScholarPubMed
Burgos, J. M., Risso, M. G., Breniere, S. F., Barnabe, C., Campetella, O. and Leguizamon, M. S. (2013). Differential distribution of genes encoding the virulence factor trans-sialidase along Trypanosoma cruzi discrete typing units. PLoS ONE 8, e58967. doi: 10.1371/journal.pone.0058967 PONE-D-12-38981 [pii].Google Scholar
Cain, B. S., Meldrum, D. R., Dinarello, C. A., Meng, X., Joo, K. S., Banerjee, A. and Harken, A. H. (1999). Tumor necrosis factor-alpha and interleukin-1beta synergistically depress human myocardial function. Critical Care Medicine 27, 1309–1318. doi: 10.1097/00003246-199907000- 00018.Google Scholar
Calvet, C. M., Melo, T. G., Garzoni, L. R., Oliveira, F. O., Neto, D. T., , N. S. L.M., Meirelles, L. and Pereira, M. C. (2012). Current understanding of the Trypanosoma cruzi-cardiomyocyte interaction. Frontiers in Immunology 3, 327. doi: 10.3389/fimmu.2012.00327.Google Scholar
Campbell, D. A., Westenberger, S. J. and Sturm, N. R. (2004). The determinants of Chagas disease: connecting parasite and host genetics. Current Molecular Medicine 4, 549–562. doi: 10.2174/1566524043360249.Google Scholar
Carranza, J. C., Valadares, H. M., D'Avila, D. A., Baptista, R. P., Moreno, M., Galvao, L. M., Chiari, E., Sturm, N. R., Gontijo, E. D., Macedo, A. M. and Zingales, B. (2009). Trypanosoma cruzi maxicircle heterogeneity in Chagas disease patients from Brazil. International Journal for Parasitology 39, 963–973. doi: S0020-7519(09)00095-2 [pii] 10.1016/j.ijpara.2009.01.009.Google Scholar
Cunha-Neto, E., Rizzo, L. V., Albuquerque, F., Abel, L., Guilherme, L., Bocchi, E., Bacal, F., Carrara, D., Ianni, B., Mady, C. and Kalil, J. (1998). Cytokine production profile of heart-infiltrating T cells in Chagas’ disease cardiomyopathy. Brazilian Journal of Medical and Biological Research 31, 133–137. doi: 10.1590/S0100-879X1998000100018.Google Scholar
Cunha-Neto, E., Dzau, V. J., Allen, P. D., Stamatiou, D., Benvenutti, L., Higuchi, M. L., Koyama, N. S., Silva, J. S., Kalil, J. and Liew, C. C. (2005). Cardiac gene expression profiling provides evidence for cytokinopathy as a molecular mechanism in Chagas’ disease cardiomyopathy. American Journal of Pathology 167, 305–313. doi: S0002-9440(10)62976-8 [pii]10.1016/S0002-9440(10)62976-8.Google Scholar
de Boer, R. A., Yu, L. and van Veldhuisen, D. J. (2010). Galectin-3 in cardiac remodeling and heart failure. Current Heart Failure Reports 7, 1–8. doi: 10.1007/s11897-010-0004-x.Google Scholar
Desmouliere, A., Redard, M., Darby, I. and Gabbiani, G. (1995). Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar. American Journal of Pathology 146, 56–66. doi: PMC1870783.Google Scholar
Di Noia, J. M., Buscaglia, C. A., De Marchi, C. R., Almeida, I. C. and Frasch, A. C. (2002). A Trypanosoma cruzi small surface molecule provides the first immunological evidence that Chagas' disease is due to a single parasite lineage. Journal of Experimental Medicine 195, 401–413. doi: 10.1084/jem.20011433.CrossRefGoogle ScholarPubMed
Dutra, W. O., Menezes, C. A., Villani, F. N., da Costa, G. C., da Silveira, A. B., Reis, D. and Gollob, K. J. (2009). Cellular and genetic mechanisms involved in the generation of protective and pathogenic immune responses in human Chagas disease. Memórias do Instituto Oswaldo Cruz 104 (Suppl. 1), 208–218. doi: S0074-02762009000900027 [pii].Google Scholar
Feldman, A. M. and McNamara, D. (2000). Myocarditis. New England Journal of Medicine 343, 1388–1398. doi: 10.1056/NEJM200011093431908.Google Scholar
Feliciangeli, M. D., Dujardin, J. P., Bastrenta, B., Mazzarri, M., Villegas, J., Flores, M. and Munoz, M. (2002). Is Rhodnius robustus (Hemiptera: Reduviidae) responsible for Chagas disease transmission in Western Venezuela? Tropical Medicine and International Health 7, 280–287. doi: 853 [pii].Google Scholar
Frangogiannis, N. G. (2006). Targeting the inflammatory response in healing myocardial infarcts. Current Medicinal Chemistry 13, 1877–1893. doi: 10.2174/092986706777585086.Google Scholar
Frangogiannis, N. G. (2008). The immune system and cardiac repair. Pharmacology Research 58, 88–111. doi: 10.1016/j.phrs.2008.06.007 S1043-6618(08)00108-4 [pii].Google Scholar
Freitas, J. M., Lages-Silva, E., Crema, E., Pena, S. D. and Macedo, A. M. (2005). Real time PCR strategy for the identification of major lineages of Trypanosoma cruzi directly in chronically infected human tissues. International Journal of Parasitology 35, 411–417. doi: S0020-7519(04)00260-7 [pii] 10.1016/j.ijpara.2004.10.023.Google Scholar
Gomez, R. M., Castagnino, C. G. and Berria, M. I. (1992). Extracellular matrix remodelling after coxsackievirus B3-induced murine myocarditis. International Journal of Experimental Pathology 73, 643–653. doi: PMC2002023.Google Scholar
Gomez, R. M., Vieira, M. L., Schattner, M., Malaver, E., Watanabe, M. M., Barbosa, A. S., Abreu, P. A., de Morais, Z. M., Cifuente, J. O., Atzingen, M. V., Oliveira, T. R., Vasconcellos, S. A. and Nascimento, A. L. (2008). Putative outer membrane proteins of Leptospira interrogans stimulate human umbilical vein endothelial cells (HUVECS) and express during infection. Microbial Pathogenesis 45, 315–322. doi: S0882-4010(08)00107-1 [pii] 10.1016/j.micpath.2008.08.004.CrossRefGoogle ScholarPubMed
Guhl, F. and Ramirez, J. D. (2011). Trypanosoma cruzi I diversity: towards the need of genetic subdivision? Acta Tropica 119, 1–4. doi: 10.1016/j.actatropica.2011.04.002 S0001-706X(11)00072-6 [pii].Google Scholar
Gurtner, G. C., Werner, S., Barrandon, Y. and Longaker, M. T. (2008). Wound repair and regeneration. Nature 453, 314–321. doi: 10.1038/nature07039 nature07039 [pii].CrossRefGoogle ScholarPubMed
Hardison, J. L., Wrightsman, R. A., Carpenter, P. M., Lane, T. E. and Manning, J. E. (2006). The chemokines CXCL9 and CXCL10 promote a protective immune response but do not contribute to cardiac inflammation following infection with Trypanosoma cruzi . Infection and Immunity 74, 125–134. doi: 74/1/125 [pii] 10.1128/IAI.74.1.125-134.2006.Google Scholar
Haudek, S. B., Taffet, G. E., Schneider, M. D. and Mann, D. L. (2007). TNF provokes cardiomyocyte apoptosis and cardiac remodeling through activation of multiple cell death pathways. Journal of Clinical Investigation 117, 2692–2701. doi: 10.1172/JCI29134.CrossRefGoogle ScholarPubMed
Henderson, N. C., Mackinnon, A. C., Farnworth, S. L., Poirier, F., Russo, F. P., Iredale, J. P., Haslett, C., Simpson, K. J. and Sethi, T. (2006). Galectin-3 regulates myofibroblast activation and hepatic fibrosis. Proceedings of the National Academy of Sciences USA 103, 5060–5065. doi: 0511167103 [pii] 10.1073/pnas.0511167103.Google Scholar
Henderson, N. C., Mackinnon, A. C., Farnworth, S. L., Kipari, T., Haslett, C., Iredale, J. P., Liu, F. T., Hughes, J. and Sethi, T. (2008). Galectin-3 expression and secretion links macrophages to the promotion of renal fibrosis. American Journal of Pathology 172, 288–298. doi: 10.2353/ajpath.2008.070726 S0002-9440(10)61796-8 [pii].Google Scholar
Jaquenod De Giusti, C., Alberdi, L., Frik, J., Ferrer, M. F., Scharrig, E., Schattner, M. and Gomez, R. M. (2011). Galectin-3 is upregulated in activated glia during Junin virus-induced murine encephalitis. Neuroscience Letters 501, 163–166. doi: 10.1016/j.neulet.2011.07.007 S0304-3940(11)01040-8 [pii].Google Scholar
Junqueira, L. C., Bignolas, G. and Brentani, R. R. (1979). Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections. Histochemistry Journal 11, 447–455. doi: 10.1007/BF01002772.Google Scholar
Kaviratne, M., Hesse, M., Leusink, M., Cheever, A. W., Davies, S. J., McKerrow, J. H., Wakefield, L. M., Letterio, J. J. and Wynn, T. A. (2004). IL-13 activates a mechanism of tissue fibrosis that is completely TGF-beta independent. Journal of Immunology 173, 4020–4029. doi: 173/6/4020 [pii].CrossRefGoogle ScholarPubMed
Kleshchenko, Y. Y., Moody, T. N., Furtak, V. A., Ochieng, J., Lima, M. F. and Villalta, F. (2004). Human galectin-3 promotes Trypanosoma cruzi adhesion to human coronary artery smooth muscle cells. Infection and Immunity 72, 6717–6721.Google Scholar
Kubota, T., McTiernan, C. F., Frye, C. S., Slawson, S. E., Lemster, B. H., Koretsky, A. P., Demetris, A. J. and Feldman, A. M. (1997). Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-alpha. Circulation Research 81, 627–635. doi: 10.1161/01.RES.81.4.627.Google Scholar
Lee, C. G., Homer, R. J., Zhu, Z., Lanone, S., Wang, X., Koteliansky, V., Shipley, J. M., Gotwals, P., Noble, P., Chen, Q., Senior, R. M. and Elias, J. A. (2001). Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor beta(1). Journal of Experimental Medicine 194, 809–821. doi: 10.1084/jem.194.6.809.Google Scholar
Liu, F. T. and Rabinovich, G. A. (2010). Galectins: regulators of acute and chronic inflammation. Annals of the New York Academy of Sciences 1183, 158–182. doi: 10.1111/j.1749-6632.2009.05131.x.CrossRefGoogle ScholarPubMed
Lok, D. J., Van Der Meer, P., de la Porte, P. W., Lipsic, E., Van Wijngaarden, J., Hillege, H. L. and van Veldhuisen, D. J. (2010). Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study. Clinical Research in Cardiology 99, 323–328. doi: 10.1007/s00392-010-0125-y.Google Scholar
Macedo, A. M., Machado, C. R., Oliveira, R. P. and Pena, S. D. (2004). Trypanosoma cruzi: genetic structure of populations and relevance of genetic variability to the pathogenesis of Chagas disease. Memórias do Instituto Oswaldo Cruz 99, 1–12. doi: S0074-02762004000100001 [pii].CrossRefGoogle Scholar
Machado, F. S., Dutra, W. O., Esper, L., Gollob, K. J., Teixeira, M. M., Factor, S. M., Weiss, L. M., Nagajyothi, F., Tanowitz, H. B. and Garg, N. J. (2012). Current understanding of immunity to Trypanosoma cruzi infection and pathogenesis of Chagas disease. Seminars in Immunopathology 34, 753–770. doi: 10.1007/s00281-012-0351-7.CrossRefGoogle ScholarPubMed
Marin-Neto, J. A., Cunha-Neto, E., Maciel, B. C. and Simoes, M. V. (2007). Pathogenesis of chronic Chagas heart disease. Circulation 115, 1109–1123. doi: 115/9/1109 [pii] 10.1161/CIRCULATIONAHA.106.624296.CrossRefGoogle ScholarPubMed
Miles, M. A., Feliciangeli, M. D. and de Arias, A. R. (2003). American trypanosomiasis (Chagas’ disease) and the role of molecular epidemiology in guiding control strategies. British Medical Journal 326, 1444–1448. doi: 10.1136/bmj.326.7404.1444 326/7404/1444 [pii].Google Scholar
Moody, T. N., Ochieng, J. and Villalta, F. (2000). Novel mechanism that Trypanosoma cruzi uses to adhere to the extracellular matrix mediated by human galectin-3. FEBS Letters 470, 305–308.CrossRefGoogle Scholar
PAHO (2007). Health conditions and trends. In Health in the Americas, Vol. 1, pp. 58–207. Pan American Health Organization, Washington, DC, USA.Google Scholar
Paiva, C. N., Figueiredo, R. T., Kroll-Palhares, K., Silva, A. A., Silverio, J. C., Gibaldi, D., Pyrrho Ados, S., Benjamim, C. F., Lannes-Vieira, J. and Bozza, M. T. (2009). CCL2/MCP-1 controls parasite burden, cell infiltration, and mononuclear activation during acute Trypanosoma cruzi infection. Journal of Leukocyte Biology 86, 1239–1246. doi: 10.1189/jlb.0309187 jlb.0309187 [pii].CrossRefGoogle ScholarPubMed
Pilling, D., Fan, T., Huang, D., Kaul, B. and Gomer, R. H. (2009). Identification of markers that distinguish monocyte-derived fibrocytes from monocytes, macrophages, and fibroblasts. PLoS ONE 4, e7475. doi: 10.1371/journal.pone.0007475.Google Scholar
Ramirez, J. D., Guhl, F., Rendon, L. M., Rosas, F., Marin-Neto, J. A. and Morillo, C. A. (2010). Chagas cardiomyopathy manifestations and Trypanosoma cruzi genotypes circulating in chronic Chagasic patients. PLoS Neglected Tropical Diseases 4, e899. doi: 10.1371/journal.pntd.0000899.Google Scholar
Rassi, A. Jr., Rassi, A. and Marin-Neto, J. A. (2010). Chagas disease. Lancet 375, 1388–1402. doi: S0140-6736(10)60061-X [pii] 10.1016/S0140-6736(10)60061-X.Google Scholar
Risso, M. G., Garbarino, G. B., Mocetti, E., Campetella, O., Gonzalez Cappa, S. M., Buscaglia, C. A. and Leguizamon, M. S. (2004). Differential expression of a virulence factor, the trans-sialidase, by the main Trypanosoma cruzi phylogenetic lineages. Journal of Infectious Disease 189, 2250–2259. doi: 10.1086/420831 JID31720 [pii].Google Scholar
Rocha Rodrigues, D. B., dos Reis, M. A., Romano, A., Pereira, S. A., Teixeira Vde, P., Tostes, S. Jr. and Rodrigues, V. Jr. (2012). In situ expression of regulatory cytokines by heart inflammatory cells in Chagas’ disease patients with heart failure. Clinical and Developmental Immunology 2012, 361730. doi: 10.1155/2012/361730.Google Scholar
Roffe, E., Rothfuchs, A. G., Santiago, H. C., Marino, A. P., Ribeiro-Gomes, F. L., Eckhaus, M., Antonelli, L. R. and Murphy, P. M. (2012). IL-10 limits parasite burden and protects against fatal myocarditis in a mouse model of Trypanosoma cruzi infection. Journal of Immunology 188, 649–660. doi: 10.4049/jimmunol.1003845 jimmunol.1003845 [pii].Google Scholar
Sato, S. and Hughes, R. C. (1994). Regulation of secretion and surface expression of Mac-2, a galactoside-binding protein of macrophages. Journal of Biological Chemistry 269, 4424–4430. doi: 10.2353/ajpath.2008.070726.Google Scholar
Shi, Q., Liu, X., Bai, Y., Cui, C., Li, J., Li, Y., Hu, S. and Wei, Y. (2011). In vitro effects of pirfenidone on cardiac fibroblasts: proliferation, myofibroblast differentiation, migration and cytokine secretion. PLoS ONE 6, e28134. doi: 10.1371/journal.pone.0028134 PONE-D-11-15265 [pii].CrossRefGoogle ScholarPubMed
Soares, M. B., de Lima, R. S., Rocha, L. L., Vasconcelos, J. F., Rogatto, S. R., dos Santos, R. R., Iacobas, S., Goldenberg, R. C., Iacobas, D. A., Tanowitz, H. B., de Carvalho, A. C. and Spray, D. C. (2010). Gene expression changes associated with myocarditis and fibrosis in hearts of mice with chronic chagasic cardiomyopathy. Journal of Infectious Disease 202, 416–426. doi: 10.1086/653481.CrossRefGoogle ScholarPubMed
Solana, M. E., Ferrer, M. F., Novoa, M. M., Song, W. C. and Gomez, R. M. (2012). Decay-accelerating factor 1 deficiency exacerbates Trypanosoma cruzi-induced murine chronic myositis. Muscle and Nerve 46, 582–587. doi: 10.1002/mus.23347.Google Scholar
Sun, Y. and Weber, K. T. (2000). Infarct scar: a dynamic tissue. Cardiovascular Research 46, 250–256. doi: S0008-6363(00)00032-8 [pii].Google Scholar
Tanowitz, H. B., Machado, F. S., Jelicks, L. A., Shirani, J., de Carvalho, A. C., Spray, D. C., Factor, S. M., Kirchhoff, L. V. and Weiss, L. M. (2009). Perspectives on Trypanosoma cruzi-induced heart disease (Chagas disease). Progress in Cardiovascular Disease 51, 524–539. doi: 10.1016/j.pcad.2009.02.001 S0033-0620(09)00012-7 [pii].CrossRefGoogle ScholarPubMed
Tarleton, R. L. (2001). Parasite persistence in the aetiology of Chagas disease. International Journal of Parasitology 31, 550–554. doi: S0020-7519(01)00158-8 [pii].Google Scholar
Tarleton, R. L. (2003). Chagas disease: a role for autoimmunity? Trends in Parasitology 19, 447–451. doi: S1471492203002228 [pii].Google Scholar
Teixeira, M. M., da Silva, F. M., Marcili, A., Umezawa, E. S., Shikanai-Yasuda, M. A., Cunha-Neto, E., Kalil, J., Stolf, N. and Stolf, A. M. (2006). Short communication: Trypanosoma cruzi lineage I in endomyocardial biopsy from a north-eastern Brazilian patient at end-stage chronic Chagasic cardiomyopathy. Tropical Medicine and International Health 11, 294–298. doi: 10.1111/j.1365-3156.2006.01575.x.Google Scholar
Turner, C. W., Lima, M. F. and Villalta, F. (2002). Trypanosoma cruzi uses a 45-kDa mucin for adhesion to mammalian cells. Biochemical and Biophysical Research Communications 290, 29–34. doi: 10.1006/bbrc.2001.6189.CrossRefGoogle ScholarPubMed
Villalta, F., Scharfstein, J., Ashton, A. W., Tyler, K. M., Guan, F., Mukherjee, S., Lima, M. F., Alvarez, S., Weiss, L. M., Huang, H., Machado, F. S. and Tanowitz, H. B. (2009). Perspectives on the Trypanosoma cruzi-host cell receptor interactions. Parasitology Research 104, 1251–1260. doi: 10.1007/s00436-009-1383-3.Google Scholar
Vray, B., Camby, I., Vercruysse, V., Mijatovic, T., Bovin, N. V., Ricciardi-Castagnoli, P., Kaltner, H., Salmon, I., Gabius, H. J. and Kiss, R. (2004). Up-regulation of galectin-3 and its ligands by Trypanosoma cruzi infection with modulation of adhesion and migration of murine dendritic cells. Glycobiology 14, 647–657. doi: 10.1093/glycob/cwh068.Google Scholar
WHO (2002). Control of Chagas disease. Report of a WHO Expert Committee. World Health Organization Technical Report Series 905, 1–109.Google Scholar
Zhu, Z., Homer, R. J., Wang, Z., Chen, Q., Geba, G. P., Wang, J., Zhang, Y. and Elias, J. A. (1999). Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. Journal of Clinical Investigation 103, 779–788. doi: 10.1172/JCI5909.Google Scholar
Zingales, B., Andrade, S. G., Briones, M. R., Campbell, D. A., Chiari, E., Fernandes, O., Guhl, F., Lages-Silva, E., Macedo, A. M., Machado, C. R., Miles, M. A., Romanha, A. J., Sturm, N. R., Tibayrenc, M., Schijman, A. G. and Second Satellite, M. (2009). A new consensus for Trypanosoma cruzi intraspecific nomenclature: second revision meeting recommends TcI to TcVI. Memórias do Instituto Oswaldo Cruz 104, 1051–1054. doi: S0074-02762009000700021 [pii].Google Scholar
Zlochiver, S., Munoz, V., Vikstrom, K. L., Taffet, S. M., Berenfeld, O. and Jalife, J. (2008). Electrotonic myofibroblast-to-myocyte coupling increases propensity to reentrant arrhythmias in two-dimensional cardiac monolayers. Biophysical Journal 95, 4469–4480. doi: 10.1529/biophysj.108.136473.Google Scholar
Figure 0

Table 1. Primers used in q-PCR assays

Figure 1

Fig. 1. DTU I isolates induce murine myocarditis to different intensities. (A) Parasitaemia levels were monitored, in T. cruzi Hc- and Ac-inoculated CF1 mice, from 14 days post-infection and the number of parasites/mL was calculated. (B) Parasite burden at hearts was quantified by q-PCR of the SNR gene and expressed as number of parasites per number of host cells. Hc- and Ac-infected CF1 mice were euthanased at 3 mpi. Bars represent the s.e.m. for assays performed on a group of five mice. Each organ was analysed independently. mpi, months post-infection. *P<0·05. (C–I) Representative histopathology sections. Samples were harvested and processed for routine staining with HE. (C) Mock-infected heart tissue. (D) T. cruzi DTU I (Hc)-infected CF1 mice showed slight myocarditis with minimal mononuclear cell infiltrate (arrows). (E) T. cruzi DTU I (Ac)-infected CF1 mice showed a moderate to intermediate myocarditis with predominant mononuclear cell infiltrates localized between necrotic muscle fibres (arrows). (F–H) T. cruzi DTU V and (I) T. cruzi DTU VI infected-CF1 mice showed normal or minimal myocarditis. Scale bar: 80 μm. (J) Quantitative measurement of CCL-2 mRNA in heart samples from mock-infected or infected animals at 3 mpi. (K) Quantitative measurement of CXCL-10 mRNA in heart samples from mock-infected or infected animals at 3 mpi. Bars represent the s.e.m. of assays from a group of 5 mice. Each organ was analysed in triplicate by q-PCR and normalized to host β-actin expression; *P<0·05 vs mock-infected.

Figure 2

Fig. 2. DTU I isolates induce murine cardiac fibrosis of different intensity. (A) Quantitative measurement of pro-collagen I mRNA in heart samples from mock-infected or infected animals at 3 mpi. Bars represent the s.e.m. of assays from a group of 5 mice. Each organ was analysed in triplicate by q-PCR and normalized to host β-actin expression; *P<0·05; (B–D) PSR staining of representative heart histology sections from T. cruzi Hc- and Ac-inoculated CF1 male mice at 3 mpi. As revealed by PSR staining, a collagen matrix made up by fibres was located within the intercellular spaces in; (B) mock-infected; (C) Hc-infected, and; (D) Ac-infected CF1 mice. Scale bar: 80 μm. mpi, months post-infection. Main PSR stains are indicated by arrows.

Figure 3

Fig. 3. Gal-3 and α-SMA expression in T. cruzi Hc- and Ac-inoculated CF1 male mice at 3 mpi. Quantitative measurements of (A) α-SMA and (E) Gal-3 mRNA expression in heart samples from CF1 mock-infected (CF1 mock) and Hc- and Ac-infected (CF1+Hc and CF1+Ac, respectively) animals at 3 mpi. Bars represent the s.e.m. of assays from a group of 5 mice. Each organ was analysed in triplicate by q-PCR and normalized to host β-actin expression; *P<0·05, **P<0·01. Immunohistochemistry of heart sections, from (B and F) mock-,-; (C and G) Hc-, and (D and H) Ac-infected CF1 mice, with antiserum specific for α-smooth muscle actin (α-SMA) or galectin-3 (Gal-3) at 3 mpi. Scale bar: 80 μm. mpi, months post-infection. Positive foci are indicated by arrows.

Figure 4

Fig. 4. mRNA cytokine levels in Ac-infected CF1 mice at 3 mpi. Quantitative measurement of (A) TGF-β1, (B) IL-13, (C) IFN-γ and (D) IL-10 mRNA expression in cardiac samples from mock-infected (CF1 mock) or infected (CF1+Ac) mice. Organs were collected at 3 mpi. Bars represent the s.e.m. of assays performed on samples from a group of 5 mice. Each organ was analysed in triplicate by q-PCR and normalized to host β-actin expression; *P<0·05 and **P<0·01 vs controls. mpi, months post-infection.